AMGEN INC
AMGEN INC
Aktie · US0311621009 · AMGN · 867900 (XNAS)
Übersicht Finanzkennzahlen
290,38 USD
-0,09 % -0,26 USD
NASDAQ (XNAS) · Aktuelle Kurse und Charts bei MoneyPeak
06.06.2025 19:19

Aktuelle Kurse von AMGEN INC

BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNAS: NASDAQ
NASDAQ
AMGN
USD
06.06.2025 19:19
290,38 USD
287,10 USD
+1,14 %
XETR: XETRA
XETRA
AMG.DE
EUR
06.06.2025 15:35
255,15 EUR
254,60 EUR
+0,22 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
-0,09 % 1,71 % 3,68 % -8,52 % 5,85 % -5,99 % 28,67 %

Firmenprofil zu AMGEN INC Aktie

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Investierte Fonds

Folgende Fonds haben in investiert: AMGEN INC investiert:

Fonds
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in Mio
2.953,80
Anteil (%)
6,93 %
Fonds
iShares Dow Jones Industrial Average UCITS ETF (DE)
Vol. in Mio
11.287,43
Anteil (%)
4,18 %
Fonds
iShares MSCI USA SRI UCITS ETF EUR Hedged (Dist)
Vol. in Mio
5.880,99
Anteil (%)
1,71 %
Fonds
iShares MSCI USA SRI UCITS ETF USD (Dist)
Vol. in Mio
6.933,02
Anteil (%)
1,71 %
Fonds
iShares MSCI World Health Care Sector UCITS ETF USD (Dist)
Vol. in Mio
6.068,54
Anteil (%)
1,66 %

Unternehmensdaten

Name AMGEN INC
Firma Amgen Inc.
Symbol AMGN
Website https://www.amgen.com
Heimatbörse XNAS NASDAQ
WKN 867900
ISIN US0311621009
Wertpapierart Aktie
Sektor Healthcare
Branche Drug Manufacturers - General
CEO Mr. Robert A. Bradway
Marktkapitalisierung 130 Mrd.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 28,0 T
Adresse One Amgen Center Drive, 91320-1799 Thousand Oaks
IPO Datum 2000-01-03
Dividenden von 'AMGEN INC'
Ex-Datum Dividende pro Aktie
16.05.2025 2,38 USD
14.02.2025 2,38 USD
18.11.2024 2,25 USD
16.08.2024 2,25 USD
16.05.2024 2,25 USD
15.02.2024 2,25 USD
16.11.2023 2,13 USD
17.08.2023 2,13 USD
17.05.2023 2,13 USD
14.02.2023 2,13 USD

Aktien-Splits

Datum Split
22.11.1999 2:1
01.03.1999 2:1
16.08.1995 2:1
11.09.1991 3:1
13.08.1990 2:1

Ticker Symbole

Name Symbol
Frankfurt AMG.F
NASDAQ AMGN
XETRA AMG.DE

Weitere Aktien

Investoren die AMGEN INC die halten, haben auch folgende Aktien im Depot:
ADOBE INC
ADOBE INC Aktie
ALLIANZ AG
ALLIANZ AG Aktie
AMAZON.CO INC
AMAZON.CO INC Aktie
APPLE INC
APPLE INC Aktie
CISCO SYSTEMS INC
CISCO SYSTEMS INC Aktie
GLOBAL CORPRATE BOND INDEX FUND - EUR HEDGED ACC
GLOBAL CORPRATE BOND INDEX FUND - EUR HEDGED ACC Fonds
INSTRUMENT DE000TT30GB7
INSTRUMENT DE000TT30GB7 Unbekannt
INTEL CORP
INTEL CORP Aktie
JOHNSON & JOHNSON
JOHNSON & JOHNSON Aktie
MICROSOFT CORP
MICROSOFT CORP Aktie
NEXITY 21/28 CV
NEXITY 21/28 CV Anleihe
PROCTER GAMBLE CORP
PROCTER GAMBLE CORP Aktie
TEXAS INSTRUMENTS INC
TEXAS INSTRUMENTS INC Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025